MDxHealth SA banner

Wall St Price Targets

O6C Price Targets Summary
MDxHealth SA

Wall Street analysts forecast O6C stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for O6C is 19.407 EUR with a low forecast of 6.626 EUR and a high forecast of 34.444 EUR.

Lowest Forecast
Price Target
6.626 EUR
115% Upside
Average Forecast
Price Target
19.407 EUR
531% Upside
Highest Forecast
Price Target
34.444 EUR
1 020% Upside
MDxHealth SA Competitors:
Price Targets
NCSM
NCS Multistage Holdings Inc
56% Upside
UFPT
UFP Technologies Inc
25% Upside
TTD
Trade Desk Inc
42% Upside

Revenue
Forecast

27% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
27% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 5 years is 8%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is O6C's stock price target?
Price Target
19.407 EUR

According to Wall Street analysts, the average 1-year price target for O6C is 19.407 EUR with a low forecast of 6.626 EUR and a high forecast of 34.444 EUR.

What is the Revenue forecast for MDxHealth SA?
Projected CAGR
8%

Over the last 14 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 5 years is 8%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett